1h Free Analyst Time
The enzyme-linked immunosorbent assay (Elisa) testing market is forecasted to grow by $564.97 mn during 2022-2027, accelerating at a CAGR of 13.6% during the forecast period. The report on the enzyme-linked immunosorbent assay (Elisa) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing need for frequent diagnostic testing among aging population, rise in toxicology testing in food industry, and the increase in chronic diseases.
The enzyme-linked immunosorbent assay (Elisa) testing market is segmented as below:
By Application
- Vaccine development
- Immunology
- Diagnostics
- Drug monitoring and pharmaceutical industry
- Others
By End-user
- Hospitals and diagnostic centers
- Research laboratories
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the enzyme-linked immunosorbent assay (Elisa) testing market covers the following areas:
- Enzyme-linked immunosorbent assay (Elisa) testing market sizing
- Enzyme-linked immunosorbent assay (Elisa) testing market forecast
- Enzyme-linked immunosorbent assay (Elisa) testing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 End User Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End User Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Vaccine development - Market size and forecast 2022-2027
Exhibit 34: Chart on Vaccine development - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Vaccine development - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Vaccine development - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Vaccine development - Year-over-year growth 2022-2027 (%)
6.4 Immunology - Market size and forecast 2022-2027
Exhibit 38: Chart on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Immunology - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
6.5 Diagnostics - Market size and forecast 2022-2027
Exhibit 42: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
6.6 Drug monitoring and pharmaceutical industry - Market size and forecast 2022-2027
Exhibit 46: Chart on Drug monitoring and pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Drug monitoring and pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Drug monitoring and pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Drug monitoring and pharmaceutical industry - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Application
Exhibit 54: Market opportunity by Application ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 55: Chart on End-user - Market share 2022-2027 (%)
Exhibit 56: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 57: Chart on Comparison by End-user
Exhibit 58: Data Table on Comparison by End-user
7.3 Hospitals and diagnostic centers - Market size and forecast 2022-2027
Exhibit 59: Chart on Hospitals and diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Hospitals and diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Hospitals and diagnostic centers - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Hospitals and diagnostic centers - Year-over-year growth 2022-2027 (%)
7.4 Research laboratories - Market size and forecast 2022-2027
Exhibit 63: Chart on Research laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Research laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Research laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Research laboratories - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 67: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 71: Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 75: Chart on Geographic comparison
Exhibit 76: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 109: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 110: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 111: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 112: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 113: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 114: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 116: Overview on factors of disruption
11.4 Industry risks
Exhibit 117: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 118: Vendors covered
12.2 Market positioning of vendors
Exhibit 119: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 120: Abbott Laboratories - Overview
Exhibit 121: Abbott Laboratories - Business segments
Exhibit 122: Abbott Laboratories - Key news
Exhibit 123: Abbott Laboratories - Key offerings
Exhibit 124: Abbott Laboratories - Segment focus
12.4 Abcam plc
Exhibit 125: Abcam plc - Overview
Exhibit 126: Abcam plc - Product / Service
Exhibit 127: Abcam plc - Key news
Exhibit 128: Abcam plc - Key offerings
12.5 Agilent Technologies Inc.
Exhibit 129: Agilent Technologies Inc. - Overview
Exhibit 130: Agilent Technologies Inc. - Business segments
Exhibit 131: Agilent Technologies Inc. - Key news
Exhibit 132: Agilent Technologies Inc. - Key offerings
Exhibit 133: Agilent Technologies Inc. - Segment focus
12.6 Avantor Inc.
Exhibit 134: Avantor Inc. - Overview
Exhibit 135: Avantor Inc. - Business segments
Exhibit 136: Avantor Inc. - Key offerings
Exhibit 137: Avantor Inc. - Segment focus
12.7 Becton Dickinson and Co.
Exhibit 138: Becton Dickinson and Co. - Overview
Exhibit 139: Becton Dickinson and Co. - Business segments
Exhibit 140: Becton Dickinson and Co. - Key news
Exhibit 141: Becton Dickinson and Co. - Key offerings
Exhibit 142: Becton Dickinson and Co. - Segment focus
12.8 Bio Rad Laboratories Inc.
Exhibit 143: Bio Rad Laboratories Inc. - Overview
Exhibit 144: Bio Rad Laboratories Inc. - Business segments
Exhibit 145: Bio Rad Laboratories Inc. - Key news
Exhibit 146: Bio Rad Laboratories Inc. - Key offerings
Exhibit 147: Bio Rad Laboratories Inc. - Segment focus
12.9 bioMerieux SA
Exhibit 148: bioMerieux SA - Overview
Exhibit 149: bioMerieux SA - Product / Service
Exhibit 150: bioMerieux SA - Key offerings
12.10 Danaher Corp.
Exhibit 151: Danaher Corp. - Overview
Exhibit 152: Danaher Corp. - Business segments
Exhibit 153: Danaher Corp. - Key news
Exhibit 154: Danaher Corp. - Key offerings
Exhibit 155: Danaher Corp. - Segment focus
12.11 Eppendorf SE
Exhibit 156: Eppendorf SE - Overview
Exhibit 157: Eppendorf SE - Product / Service
Exhibit 158: Eppendorf SE - Key news
Exhibit 159: Eppendorf SE - Key offerings
12.12 Merck KGaA
Exhibit 160: Merck KGaA - Overview
Exhibit 161: Merck KGaA - Business segments
Exhibit 162: Merck KGaA - Key news
Exhibit 163: Merck KGaA - Key offerings
Exhibit 164: Merck KGaA - Segment focus
12.13 Novo Nordisk AS
Exhibit 165: Novo Nordisk AS - Overview
Exhibit 166: Novo Nordisk AS - Business segments
Exhibit 167: Novo Nordisk AS - Key offerings
Exhibit 168: Novo Nordisk AS - Segment focus
12.14 Perkin Elmer Inc
Exhibit 169: Perkin Elmer Inc - Overview
Exhibit 170: Perkin Elmer Inc - Business segments
Exhibit 171: Perkin Elmer Inc - Key news
Exhibit 172: Perkin Elmer Inc - Key offerings
Exhibit 173: Perkin Elmer Inc - Segment focus
12.15 QIAGEN NV
Exhibit 174: QIAGEN NV - Overview
Exhibit 175: QIAGEN NV - Product / Service
Exhibit 176: QIAGEN NV - Key news
Exhibit 177: QIAGEN NV - Key offerings
12.16 Siemens Healthineers AG
Exhibit 178: Siemens Healthineers AG - Overview
Exhibit 179: Siemens Healthineers AG - Business segments
Exhibit 180: Siemens Healthineers AG - Key news
Exhibit 181: Siemens Healthineers AG - Key offerings
Exhibit 182: Siemens Healthineers AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 183: Thermo Fisher Scientific Inc. - Overview
Exhibit 184: Thermo Fisher Scientific Inc. - Business segments
Exhibit 185: Thermo Fisher Scientific Inc. - Key news
Exhibit 186: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 187: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 188: Inclusions checklist
Exhibit 189: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 190: Currency conversion rates for US$
13.4 Research methodology
Exhibit 191: Research methodology
Exhibit 192: Validation techniques employed for market sizing
Exhibit 193: Information sources
13.5 List of abbreviations
Exhibit 194: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - End User Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Application - Market share 2022-2027 (%)
Exhibits 31: Data Table on Application - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Vaccine development - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Vaccine development - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Vaccine development - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Vaccine development - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Drug monitoring and pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on Drug monitoring and pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on Drug monitoring and pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Drug monitoring and pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Application ($ million)
Exhibits 55: Chart on End-user - Market share 2022-2027 (%)
Exhibits 56: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 57: Chart on Comparison by End-user
Exhibits 58: Data Table on Comparison by End-user
Exhibits 59: Chart on Hospitals and diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibits 60: Data Table on Hospitals and diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Chart on Hospitals and diagnostic centers - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on Hospitals and diagnostic centers - Year-over-year growth 2022-2027 (%)
Exhibits 63: Chart on Research laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on Research laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on Research laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on Research laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 71: Market opportunity by End-user ($ million)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 109: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 110: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 111: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 112: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 113: Market opportunity By Geographical Landscape ($ million)
Exhibits 114: Impact of drivers and challenges in 2022 and 2027
Exhibits 115: Overview on Criticality of inputs and Factors of differentiation
Exhibits 116: Overview on factors of disruption
Exhibits 117: Impact of key risks on business
Exhibits 118: Vendors covered
Exhibits 119: Matrix on vendor position and classification
Exhibits 120: Abbott Laboratories - Overview
Exhibits 121: Abbott Laboratories - Business segments
Exhibits 122: Abbott Laboratories - Key news
Exhibits 123: Abbott Laboratories - Key offerings
Exhibits 124: Abbott Laboratories - Segment focus
Exhibits 125: Abcam plc - Overview
Exhibits 126: Abcam plc - Product / Service
Exhibits 127: Abcam plc - Key news
Exhibits 128: Abcam plc - Key offerings
Exhibits 129: Agilent Technologies Inc. - Overview
Exhibits 130: Agilent Technologies Inc. - Business segments
Exhibits 131: Agilent Technologies Inc. - Key news
Exhibits 132: Agilent Technologies Inc. - Key offerings
Exhibits 133: Agilent Technologies Inc. - Segment focus
Exhibits 134: Avantor Inc. - Overview
Exhibits 135: Avantor Inc. - Business segments
Exhibits 136: Avantor Inc. - Key offerings
Exhibits 137: Avantor Inc. - Segment focus
Exhibits 138: Becton Dickinson and Co. - Overview
Exhibits 139: Becton Dickinson and Co. - Business segments
Exhibits 140: Becton Dickinson and Co. - Key news
Exhibits 141: Becton Dickinson and Co. - Key offerings
Exhibits 142: Becton Dickinson and Co. - Segment focus
Exhibits 143: Bio Rad Laboratories Inc. - Overview
Exhibits 144: Bio Rad Laboratories Inc. - Business segments
Exhibits 145: Bio Rad Laboratories Inc. - Key news
Exhibits 146: Bio Rad Laboratories Inc. - Key offerings
Exhibits 147: Bio Rad Laboratories Inc. - Segment focus
Exhibits 148: bioMerieux SA - Overview
Exhibits 149: bioMerieux SA - Product / Service
Exhibits 150: bioMerieux SA - Key offerings
Exhibits 151: Danaher Corp. - Overview
Exhibits 152: Danaher Corp. - Business segments
Exhibits 153: Danaher Corp. - Key news
Exhibits 154: Danaher Corp. - Key offerings
Exhibits 155: Danaher Corp. - Segment focus
Exhibits 156: Eppendorf SE - Overview
Exhibits 157: Eppendorf SE - Product / Service
Exhibits 158: Eppendorf SE - Key news
Exhibits 159: Eppendorf SE - Key offerings
Exhibits 160: Merck KGaA - Overview
Exhibits 161: Merck KGaA - Business segments
Exhibits 162: Merck KGaA - Key news
Exhibits 163: Merck KGaA - Key offerings
Exhibits 164: Merck KGaA - Segment focus
Exhibits 165: Novo Nordisk AS - Overview
Exhibits 166: Novo Nordisk AS - Business segments
Exhibits 167: Novo Nordisk AS - Key offerings
Exhibits 168: Novo Nordisk AS - Segment focus
Exhibits 169: Perkin Elmer Inc - Overview
Exhibits 170: Perkin Elmer Inc - Business segments
Exhibits 171: Perkin Elmer Inc - Key news
Exhibits 172: Perkin Elmer Inc - Key offerings
Exhibits 173: Perkin Elmer Inc - Segment focus
Exhibits 174: QIAGEN NV - Overview
Exhibits 175: QIAGEN NV - Product / Service
Exhibits 176: QIAGEN NV - Key news
Exhibits 177: QIAGEN NV - Key offerings
Exhibits 178: Siemens Healthineers AG - Overview
Exhibits 179: Siemens Healthineers AG - Business segments
Exhibits 180: Siemens Healthineers AG - Key news
Exhibits 181: Siemens Healthineers AG - Key offerings
Exhibits 182: Siemens Healthineers AG - Segment focus
Exhibits 183: Thermo Fisher Scientific Inc. - Overview
Exhibits 184: Thermo Fisher Scientific Inc. - Business segments
Exhibits 185: Thermo Fisher Scientific Inc. - Key news
Exhibits 186: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 187: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 188: Inclusions checklist
Exhibits 189: Exclusions checklist
Exhibits 190: Currency conversion rates for US$
Exhibits 191: Research methodology
Exhibits 192: Validation techniques employed for market sizing
Exhibits 193: Information sources
Exhibits 194: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global enzyme-linked immunosorbent assay (elisa) testing market: Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Amgen Inc., Avantor Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Cardinal Health Inc., Crux Biolabs Pty Ltd., Danaher Corp., Eppendorf SE, Illumina Inc., Lonza Group Ltd., Merck KGaA, Novo Nordisk AS, Perkin Elmer Inc, QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the growing importance of promotional activities.`
According to the report, one of the major drivers for this market is the growing need for frequent diagnostic testing among the aging population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Abcam plc
- Agilent Technologies Inc.
- Amgen Inc.
- Avantor Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- bioMerieux SA
- Cardinal Health Inc.
- Crux Biolabs Pty Ltd.
- Danaher Corp.
- Eppendorf SE
- Illumina Inc.
- Lonza Group Ltd.
- Merck KGaA
- Novo Nordisk AS
- Perkin Elmer Inc
- QIAGEN NV
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
